Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ACCEL Lite: PANTHER-P2Y12 Inhibitor or Aspirin moNoTHERapy as Secondary Prevention in Patients with CADIn this interview, Alison L. Bailey, MD, FACC and Prof. Marco Valgimigli discuss “PANTHER-P2Y12 Inhibitor or Aspirin moNoTHERapy as Secondary Prevention in Patients with CADâ€.
- Patients With Chronic Conditions Exhibit Significant Quality of Life Improvements Post TAVI | NCDR StudyAlthough chronic conditions are associated with worse survival following transcatheter aortic valve implantation (TAVI), a recent study published in JACC: Advances found that most patients with multiple chronic conditions (MCC) are alive one year post TAVI and show significant improvement in quality of life.
- New in Clinical Guidance | Key Points From the 2025 Advanced Training Statement on Advanced CV ImagingThe following are key points from the 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee...
- Demystifying Antiplatelet Therapy Duration Following Percutaneous Coronary InterventionThe optimal management of dual antiplatelet therapy (DAPT) in patients presenting with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) remains a dynamic and evolving area.
- DANISH Extended Follow-Up: Who Benefits Most From Primary Prevention ICD Implantation?Primary prevention implantable cardioverter-defibrillator (ICD) implantation did not reduce all-cause death but did reduce sudden cardiovascular death in patients with nonischemic heart failure with reduced ejection fraction (HFrEF), with possible greater benefit in younger patients...